title: [Longitudinal follow-up of the IPSS within the 5 years following treatment of a localized prostate cancer: overall analysis and by type of treatment].
abstract: OBJECTIVE
  The International Prostate Score Symptom (IPSS) and the question of quality of life (QOL-Q) associated were used in this study for monitoring patients treated for localized prostate cancer (P-Ca).
  
  
  METHODS
  Three groups treated with radical prostatectomy (RP), external beam radiotherapy (RT) or brachytherapy (BRACHY) completed the self-administered questionnaire IPSS and Q-QOL before treatment (bef-TT), after 3 months and once a year for 5 years.
  
  
  RESULTS
  The study included 40 PR, 40 RT and 40 BRACHY. There was no difference between the three groups in bef-TT for the IPSS and Q-QOL or in the patients' characteristics, and P-Ca except for age and a higher PSA in the RT group (70.6 years old and 10.0 ng/mL vs. 66.5/66.2 and 7.1/6.2 for RP and CURIE respectively). The impact, no matter what treatment they received, was significant after the third month and then went back to the pre-AN1 at TT. The analysis by group treatment showed no significant difference between groups at 3months and during the first 4 years of follow-up. In the fifth year the RT group had a greater IPSS than BRACHY and PR groups (P<0.04).
  
  
  CONCLUSIONS
  This study showed no degradation of the IPSS or Q-QOL remote treatment of localized prostate cancer. Urinary incontinence has been partially exploring. His study would have allowed a better urinary quality of life analysis in these patients.
authors.affiliation: Service d'urologie, CHU La Milétrie, 2, rue de la Milétrie, 86000 Poitiers, France. Electronic address: lorionrom@hotmail.com.
authors.forename: R
authors.initials: R
authors.lastname: Lorion
authors.affiliation: Service de radiothérapie, CHU La Milétrie, 86000 Poitiers, France.
authors.forename: S
authors.initials: S
authors.lastname: Guérif
authors.affiliation: Service de radiothérapie, CHU La Milétrie, 86000 Poitiers, France.
authors.forename: P
authors.initials: P
authors.lastname: Bouchaert
authors.affiliation: Service d'urologie, CHU La Milétrie, 2, rue de la Milétrie, 86000 Poitiers, France.
authors.forename: O
authors.initials: O
authors.lastname: Celhay
authors.affiliation: Service d'urologie, CHU La Milétrie, 2, rue de la Milétrie, 86000 Poitiers, France.
authors.forename: B
authors.initials: B
authors.lastname: Doré
authors.affiliation: Service d'anatomo-cytopathologie, CHU La Milétrie, 86000 Poitiers, France.
authors.forename: G
authors.initials: G
authors.lastname: Fromont
authors.affiliation: Service d'urologie, CHU La Milétrie, 2, rue de la Milétrie, 86000 Poitiers, France.
authors.forename: J
authors.initials: J
authors.lastname: Irani
mesh_terms: D000368:Aged; D015331:Cohort Studies; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000628:therapy*; D011788:Quality of Life; D012189:Retrospective Studies; D063189:Symptom Assessment; D013997:Time Factors
keywords: Brachytherapy; Cancer de prostate; Curiethérapie; External beam radiotherapy; IPSS; Prostate cancer; Prostatectomie radicale; Radical prostatectomy; Radiothérapie externe; Score de qualité de vie mictionnelle; Urinary quality of life score